Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis

Urologic Oncology: Seminars and Original Investigations

Volumn 27, Issue 4, 2009, Pages 377-381

  de Sá, Vanessa K ^a   Canavez, Flávio C ^b   Silva, Iran A ^a   Srougi, Miguel ^a   Leite, Katia R M ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Genoa Biotechnology SA   (Brazil)

Author keywords

Alternative splicing; Hyaluronan; Hyaluronidases; Prognosis; Prostate cancer

Indexed keywords

HYALURONIDASE; ISOENZYME;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FOLLOW UP; GLEASON SCORE; HUMAN; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION;

AGED; ALTERNATIVE SPLICING; DISEASE PROGRESSION; DNA PRIMERS; HUMANS; HYALURONOGLUCOSAMINIDASE; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; RECURRENCE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 67649380507     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2008.04.013     Document Type: Article

References (21)

1. American Cancer Society. Cancer facts and figures, 2007. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf [Accessed September 2, 2007]
2. Graefen M., Karakiewicz P.I., Cagiannos I., et al. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. Urol Oncol 7 (2002) 141-146
3. Stern R. Devising a pathway for hyaluronan catabolism: Are we there yet?. Glycobiology 12 (2003) 105-115
4. Delpech B., Girard N., Bertrand P., et al. Hyaluronan: Fundamental principles and applications in cancer. J Intern Med 242 (1997) 41-48
5. Turley E.A., Noble P.W., and Bourguignon L.Y.W. Signaling properties of hyaluronan receptors. J Biol Chem 277 (2002) 4589-4592
6. Herrlich P., Morrison H., Sleeman J., et al. CD44 acts both as a growth and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann NY Acad Sci 910 (2000) 106-118
7. Posey T., Soloway M.S., Ekici S., et al. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer. Cancer Res 63 (2003) 2638-2644
8. Pirinen R., Tammi R., Tammi M., et al. Prognostic value of hyaluronan expression in non-small cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer 95 (2001) 12-17
9. Ropponen K., Tammi M., Parkkinen J., et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58 (1998) 342-347
10. Hobarth K., Maier U., and Marberger M. Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase. Eur Urol 21 (1992) 206-210
11. Rein DT, Roehrig K, Schondorf T, et al. Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumor progression and metastasis. J Cancer Res Clin Oncol 203;129:161-4.
12. Lokeshwar V.B., Obek C., Soloway M.S., et al. Tumor associated hyaluronic acid: A new sensitive and specific urine marker for bladder cancer. Cancer Res 58 (1998) 31-41
13. Lokeshwar V.B., Rubinowicz D., Schroeder G.L., et al. Stromal and epithelial expression of tumor markers hyaluronic acid and hyaluronidase in prostate cancer. J Biol Chem 276 (1998) 11922-11932
14. Markovic-Housley Z., Miglierini G., Soldatova L., et al. Crystal structure of hyaluronidase, a major allergen of bee venom. Structure 8 (2000) 1025-1035
15. Halici M., Karaoglu S., Canoz O., et al. Sodium hyaluronate regulating angiogenesis during Achilles tendon healing. Knee Surg Sports Traumatol Arthrosc 12 (2004) 562-567
16. Harada H., and Takahashi M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem 282 (2007) 5597-5607
17. Chao K.L., Muthukumar L., and Herzberg O. Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis. Biochemistry 46 (2007) 6911-6920
18. Lokeshwar V.B., Schroeder G.L., Carey R.I., et al. Regulation of hyaluronidase activity by alternative mRNA splicing. J Biol Chem 277 (2002) 33654-33663
19. Bertrand P., Courel M.N., Maingonnat C., et al. Expression of HYAL2 mRNA, hyaluronan, and hyaluronidase in B-cell non-Hodgkin lymphoma. Relationship with tumor aggressiveness. Int J Cancer 113 (2006) 207-212
20. Li R., Todd N.W., Qiu Q., et al. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res 13 (2007) 482-487
21. Lexander H., Franzén B., Hirschberg D., et al. Differential protein expression in anatomical zones of the prostate. Proteomics 5 (2005) 2570-2576